Trials / Completed
CompletedNCT03352726
A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
An Open-label Phase I Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- DBV Technologies · Industry
- Sex
- All
- Age
- 12 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to assess the biological potency of the In-House Reference Preparation (IHRP) of peanut allergens extract by a quantitative Skin Prick Test (SPT) method in peanut-allergic subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DBV712 IHRP | DBV712 Solution for Skin Prick Test |
Timeline
- Start date
- 2017-11-24
- Primary completion
- 2018-06-29
- Completion
- 2018-06-29
- First posted
- 2017-11-24
- Last updated
- 2019-07-26
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03352726. Inclusion in this directory is not an endorsement.